College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
Department of Ophthalmology & Visual Sciences, University of Alberta, Edmonton, AB, Canada.
Eye (Lond). 2023 Oct;37(15):3271-3281. doi: 10.1038/s41433-023-02504-0. Epub 2023 Mar 21.
BACKGROUND/OBJECTIVES: Ocular syphilis is a vision-threatening disease that can lead to permanent blindness if left untreated. The global re-emergence of syphilis warrants greater investigations into the visual prognosis of eyes affected by this potentially devastating disease. This systematic review investigates the impact of HIV on visual acuity (VA) outcomes in ocular syphilis.
A literature search of Medline, PubMed, Embase, Clinicaltrials.gov and Cochrane Reviews was conducted for studies published between 01 January 2011 and 19 March 2022, reporting non-aggregate initial and post-treatment VA data of eyes with ocular syphilis and corresponding HIV status in patients ≥ 18 years.
A total of 95 studies, including 364 patients and 568 eyes, were evaluated. Among people living with HIV with a diagnosis of ocular syphilis, affected eyes were more likely to have optic nerve involvement and panuveitis. However, HIV status, CD4 cell count, and HIV viral load were not predictive of VA outcomes of treated ocular syphilis. Prognostic factors of final VA worse than 1.00 logMAR were female sex, the presence of macular edema, and VA ≥ 1.00 at presentation. The strongest predictor of a worse final VA was VA ≥ 1.00 at presentation.
This systematic review demonstrates that HIV status, CD4 cell count, and HIV viral load are not significant factors impacting VA outcomes of eyes with ocular syphilis. While visual prognosis is generally good, poor visual outcome is most strongly predicted by poor VA at presentation. This underscores the importance of early recognition and treatment prior to permanent vision loss.
背景/目的:眼部梅毒是一种威胁视力的疾病,如果不治疗,可能导致永久性失明。梅毒在全球再次出现,需要更多地研究这种可能导致视力严重受损的疾病对受影响眼睛的视觉预后。本系统评价研究了 HIV 对眼部梅毒患者视力(VA)结局的影响。
对 2011 年 1 月 1 日至 2022 年 3 月 19 日期间发表的研究进行了 Medline、PubMed、Embase、Clinicaltrials.gov 和 Cochrane Reviews 的文献检索,这些研究报告了≥18 岁的眼部梅毒患者和相应 HIV 状态的非聚合初始和治疗后 VA 数据。
共评估了 95 项研究,包括 364 例患者和 568 只眼。在诊断为眼部梅毒的 HIV 感染者中,受影响的眼睛更有可能出现视神经受累和全葡萄膜炎。然而,HIV 状态、CD4 细胞计数和 HIV 病毒载量并不能预测治疗后眼部梅毒的 VA 结局。最终 VA 差于 1.00 logMAR 的预后因素是女性、存在黄斑水肿和初始 VA≥1.00。VA 初始值≥1.00 是最终 VA 更差的最强预测因素。
本系统评价表明,HIV 状态、CD4 细胞计数和 HIV 病毒载量不是影响眼部梅毒患者 VA 结局的重要因素。尽管视觉预后总体良好,但较差的视觉预后主要由初始 VA 较差预测。这强调了在永久性视力丧失之前早期识别和治疗的重要性。